• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Context Therapeutics Inc. - Common Stock (NQ:CNTX)

2.170 +0.020 (+0.93%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 407,959
Open 2.140
Bid (Size) 2.120 (2,800)
Ask (Size) 2.220 (100)
Prev. Close 2.150
Today's Range 2.085 - 2.190
52wk Range 0.4900 - 3.620
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Context Therapeutics Enters into License Agreement Amendment with BioAtla for CT-202
May 18, 2026
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics Reports First Quarter 2026 Operating and Financial Results
May 06, 2026
From Context Therapeutics Inc.
Via GlobeNewswire

Performance

YTD
+40.0%
+40.0%
1 Month
-4.0%
-4.0%
3 Month
-6.9%
-6.9%
6 Month
+100.9%
+100.9%
1 Year
+207.2%
+207.2%

More News

Read More
News headline image
Context Therapeutics Announces CTIM-76 Receives FDA Fast Track Designation for the Treatment of Platinum-Resistant Ovarian Cancer
April 02, 2026
From Context Therapeutics Inc.
Via GlobeNewswire
There are notable gap-ups and gap-downs in today's session. ↗
March 24, 2026
Via Chartmill
News headline image
Context Therapeutics Reports Full Year 2025 Operating and Financial Results
March 23, 2026
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics Announces Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2026
March 19, 2026
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics to Participate in Upcoming Investor Conferences
February 09, 2026
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
January 16, 2026
From Context Therapeutics Inc.
Via GlobeNewswire
Wondering what's happening in today's after-hours session? ↗
January 05, 2026
Via Chartmill
News headline image
Kartoon Studios (NYSE: TOON) Expansion Fuels 2026-2027 Upside – DVLT, UFG, VRME, ARBE More Inside
January 05, 2026
Via AB Newswire
Topics Artificial Intelligence
News headline image
Context Therapeutics Highlights CT-95 and CT-202 Programs at 2025 SITC Annual Meeting
November 07, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Cancer Drug Developers Secure Regulatory Clarity as FDA Reshapes Approval Standards
December 16, 2025
From Equity Insider
Via GlobeNewswire
News headline image
Context Therapeutics Reports Third Quarter 2025 Operating and Financial Results
November 05, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics to Participate in Upcoming Investor Conferences
October 28, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics Announces Poster Presentations at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting
October 06, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 03, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
This Synopsys Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday ↗
October 02, 2025
Via Benzinga
News headline image
Context Therapeutics to Participate in Upcoming Investor Conferences
August 27, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
CONTEXT THERAPEUTICS INC (NASDAQ:CNTX) Posts Wider Q2 2025 Loss Amid Continued Pipeline Progress ↗
August 06, 2025
Via Chartmill
News headline image
Context Therapeutics Reports Second Quarter 2025 Operating and Financial Results
August 06, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
June 05, 2025
Via Benzinga
News headline image
Context Therapeutics Announces CTIM-76 Trial in Progress Poster Presentation at 2025 ASCO Meeting
June 02, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer
May 29, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 12, 2025
From Context Therapeutics Inc.
Via GlobeNewswire
News headline image
Context Therapeutics Reports First Quarter 2025 Operating and Financial Results
May 07, 2025
From Context Therapeutics Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Context Therapeutics Inc. - Common Stock publicly traded?
Yes, Context Therapeutics Inc. - Common Stock is publicly traded.
What exchange does Context Therapeutics Inc. - Common Stock trade on?
Context Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Context Therapeutics Inc. - Common Stock?
The ticker symbol for Context Therapeutics Inc. - Common Stock is CNTX on the Nasdaq Stock Market
What is the current price of Context Therapeutics Inc. - Common Stock?
The current price of Context Therapeutics Inc. - Common Stock is 2.170
When was Context Therapeutics Inc. - Common Stock last traded?
The last trade of Context Therapeutics Inc. - Common Stock was at 05/19/26 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap